AKBA 8-K 2026-06-30

Akebia Therapeutics, Inc. (AKBA) 8-K dated 2026-06-30 — accession 0001517022-26-000047. This URL is the filing, not the AKBA hub.

Akebia Therapeutics, Inc. (AKBA) is a drug manufacturers - specialty & generic company listed on US.

Akebia Therapeutics, Inc. filed a 8-K on 2026-06-30. Accession 0001517022-26-000047.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.

Not investment advice. The AKBA SEC hub lists recent forms. The stock page is the research view.